Analystreport

Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at Wells Fargo & Company from $51.00 to $71.00.

Prometheus Biosciences, Inc.  (RXDX) 
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ignyta.com